Cargando…
How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation?
Diagnosis of sepsis is based on recognition of systemic inflammation and organ failure in the context of an inciting infection. Since none of the diagnostic criteria are specific to sepsis, it is easy to confound sepsis with noninfectious causes of systemic inflammation, including pancreatitis, card...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152028/ http://dx.doi.org/10.1016/B978-0-323-64068-8.00055-9 |
_version_ | 1783521385436413952 |
---|---|
author | Binnie, Alexandra Lage, Joel Dos Santos, Claudia C. |
author_facet | Binnie, Alexandra Lage, Joel Dos Santos, Claudia C. |
author_sort | Binnie, Alexandra |
collection | PubMed |
description | Diagnosis of sepsis is based on recognition of systemic inflammation and organ failure in the context of an inciting infection. Since none of the diagnostic criteria are specific to sepsis, it is easy to confound sepsis with noninfectious causes of systemic inflammation, including pancreatitis, cardiac ischemia, bowel perforation, vasculitis, and pulmonary embolism amongst others. Two widely used biomarkers, C-reactive protein and procalcitonin, have proven promising in sepsis diagnosis. Each has found varying success in the clinical context, with some centers relying heavily on these markers and others eschewing their use almost entirely. In this chapter, we present the evidence for their use in the diagnosis of sepsis and management of antibiotic therapy in the intensive care unit context. |
format | Online Article Text |
id | pubmed-7152028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71520282020-04-13 How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation? Binnie, Alexandra Lage, Joel Dos Santos, Claudia C. Evidence-Based Practice of Critical Care Article Diagnosis of sepsis is based on recognition of systemic inflammation and organ failure in the context of an inciting infection. Since none of the diagnostic criteria are specific to sepsis, it is easy to confound sepsis with noninfectious causes of systemic inflammation, including pancreatitis, cardiac ischemia, bowel perforation, vasculitis, and pulmonary embolism amongst others. Two widely used biomarkers, C-reactive protein and procalcitonin, have proven promising in sepsis diagnosis. Each has found varying success in the clinical context, with some centers relying heavily on these markers and others eschewing their use almost entirely. In this chapter, we present the evidence for their use in the diagnosis of sepsis and management of antibiotic therapy in the intensive care unit context. 2020 2019-09-24 /pmc/articles/PMC7152028/ http://dx.doi.org/10.1016/B978-0-323-64068-8.00055-9 Text en Copyright © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Binnie, Alexandra Lage, Joel Dos Santos, Claudia C. How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation? |
title | How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation? |
title_full | How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation? |
title_fullStr | How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation? |
title_full_unstemmed | How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation? |
title_short | How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation? |
title_sort | how can biomarkers be used to differentiate between infection and non-infectious causes of inflammation? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152028/ http://dx.doi.org/10.1016/B978-0-323-64068-8.00055-9 |
work_keys_str_mv | AT binniealexandra howcanbiomarkersbeusedtodifferentiatebetweeninfectionandnoninfectiouscausesofinflammation AT lagejoel howcanbiomarkersbeusedtodifferentiatebetweeninfectionandnoninfectiouscausesofinflammation AT dossantosclaudiac howcanbiomarkersbeusedtodifferentiatebetweeninfectionandnoninfectiouscausesofinflammation |